Efficiacy of resveratrol and quercetin after experimental spinal cord injury;Deneysel spinal kord travması sonrası resveratrol ve kuersetin’in etkinliğinin araştırılması

Ulusal Travma ve Acil Cerrahi Dergisi

Volumn 22, Issue 5, 2016, Pages 423-431

  Çiftçi, Ulvi ^a   Delen, Emre ^b   Vural, Murat ^c   Uysal, Onur ^c   Coşan, Didem Turgut ^d   Baydemir, Canan ^e   Doğaner, Fulya ^d  

^a BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

^d ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

^e KOCAELI UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Experimental spinal cord injury; Quercetin; Resveratrol

Indexed keywords

ARYLDIALKYLPHOSPHATASE; QUERCETIN; RESVERATROL; ANTIOXIDANT; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLEEDING; CELL DAMAGE; CONTROLLED STUDY; DRUG EFFICACY; EDEMA; ENZYME ACTIVITY; HISTOPATHOLOGY; LYMPHOCYTIC INFILTRATION; MALE; MICROGLIA; NECROSIS; NERVE FIBER DEGENERATION; NONHUMAN; OXIDATIVE STRESS; RAT; SPINAL CORD INJURY; ANIMAL; DISEASE MODEL; INFLAMMATION; PATHOLOGY; SPINAL CORD INJURIES; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; OXIDATIVE STRESS; QUERCETIN; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD INJURIES; STILBENES;

EID: 84986327476     PISSN: 1306696X     EISSN: None     Source Type: Journal    
DOI: 10.5505/tjtes.2016.44575     Document Type: Article

References (32)

1. Profyris C, Cheema SS, Zang D, Azari MF, Boyle K, Petratos S. Degenerative and regenerative mechanisms governing spinal cord injury. Neurobiol Dis 2004;15:415-36. Crossref
2. Yang YB, Piao YJ. Effects of resveratrol on secondary damages after acute spinal cord injury in rats. Acta Pharmacol Sin 2003;24:703-10.
3. Li Y, Cao Z, Zhu H. Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol Res 2006;53:6-15. Crossref
4. Rubiolo JA, Lopez-Alonso H, Martin-Vazquez V, Fol-Rodriguez NM, Vieytes MR, Botana LM, et al. Resveratrol inhibits proliferation of primary rat hepatocytes in G0/G1 by inhibiting DNA synthesis. Folia Biol (Praha) 2012;58:166-72.
5. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002;22:19-34. Crossref
6. Moutsatsou P. The spectrum of phytoestrogens in nature: our knowledge is expanding. Hormones (Athens) 2007;6:173-93.
7. Chattopadhyay P, Shukla G, Wahi AK. Protective effect of L-arginine against necrosis and apoptosis induced by experimental ischemic and reperfusion in rat liver. Saudi J Gastroenterol 2009;15:156-62. Crossref
8. Rajević N, Matković H, Gregorović G, Kovacević G, Knezović L, Kalafatić M. Behavioral, morphological and histopathological effects of sublethal doses of quercetin on the species Polycelis felina (Dalyell). Folia Biol (Krakow) 2013;61:101-6. Crossref
9. Ciftci O, Vardi N, Ozdemir I. Effects of quercetin and chrysin on 2,3,7,8-tetrachlorodibenzo-p-dioxin induced hepatotoxicity in rats. Environ Toxicol 2013;28:146-54. Crossref
10. Selvakumar K, Bavithra S, Krishnamoorthy G, Venkataraman P, Arunakaran J. Polychlorinated biphenyls-induced oxidative stress on rat hippocampus: a neuroprotective role of quercetin. ScientificWorldJournal 2012;2012:980314. Crossref
11. Kiziltepe U, Turan NN, Han U, Ulus AT, Akar F. Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. J Vasc Surg 2004;40:138-45. Crossref
12. Cemil B, Topuz K, Demircan MN, Kurt G, Tun K, Kutlay M, et al. Curcumin improves early functional results after experimental spinal cord injury. Acta Neurochir (Wien) 2010;152:1583-90. Crossref
13. Ates O, Cayli S, Altinoz E, Gurses I, Yucel N, Sener M, et al. Neuroprotection by resveratrol against traumatic brain injury in rats. Mol Cell Biochem 2007;294:137-44. Crossref
14. Dajas F, Rivera-Megret F, Blasina F, Arredondo F, Abin-Carriquiry JA, Costa G, et al. Neuroprotection by flavonoids. Braz J Med Biol Res 2003;36:1613-20. Crossref
15. Esposito E, Rotilio D, Di Matteo V, Di Giulio C, Cacchio M, Algeri S. A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiol Aging 2002;23:719-35. Crossref
16. Zimmermann M, Colciaghi F, Cattabeni F, Di Luca M. Ginkgo biloba extract: from molecular mechanisms to the treatment of Alzhelmer’s disease. Cell Mol Biol (Noisy-le-grand) 2002;48:613-23.
17. Genovese T, Mazzon E, Menegazzi M, Di Paola R, Muia C, Crisafulli C, et al. Neuroprotection and enhanced recovery with hypericum perforatum extract after experimental spinal cord injury in mice. Shock 2006;25:608-17. Crossref
18. Schultke E, Kamencic H, Skihar VM, Griebel R, Juurlink B. Quercetin in an animal model of spinal cord compression injury: correlation of treatment duration with recovery of motor function. Spinal Cord 2010;48:112-7. Crossref
19. Schultke E, Kendall E, Kamencic H, Ghong Z, Griebel RW, Juurlink BH. Quercetin promotes functional recovery following acute spinal cord injury. J Neurotrauma 2003;20:583-91. Crossref
20. Costa LG, Vitalone A, Cole TB, Furlong CE. Modulation of paraoxonase (PON1) activity. Biochem Pharmacol 2005;69:541-50. Crossref
21. Mackness B, McElduff P, Mackness MI. The paraoxonase-2-310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus. J Intern Med 2005;258:363-8. Crossref
22. Baum L, Ng HK, Woo KS, Tomlinson B, Rainer TH, Chen X, et al. Paraoxonase 1 gene Q192R polymorphism affects stroke and myocardial infarction risk. Clin Biochem 2006;39:191-5. Crossref
23. Ferretti G, Bacchetti T, Busni D, Rabini RA, Curatola G. Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients. J Clin Endocrinol Metab 2004;89:2957-62.
24. Ferretti G, Bacchetti T, Moroni C, Vignini A, Curatola G. Copper-induced oxidative damage on astrocytes: protective effect exerted by human high density lipoproteins. Biochim Biophys Acta 2003;1635:48-54.
25. Rael LT, Bar-Or R, Aumann RM, Slone DS, Mains CW, Bar-Or D. Oxidation-reduction potential and paraoxonase-arylesterase activity in trauma patients. Biochem Biophys Res Commun 2007;361:561-5.
26. Ates O, Cayli S, Altinoz E, Gurses I, Yucel N, Kocak A, et al. Effects of resveratrol and methylprednisolone on biochemical, neurobehavioral and histopathological recovery after experimental spinal cord injury. Acta Pharmacol Sin 2006;27:1317-25. Crossref
27. Elmali N, Esenkaya I, Karadağ N, Taş F, Elmali N. Effects of resveratrol on skeletal muscle in ischemia-reperfusion injury. Ulus Travma Acil Cerrahi Derg 2007;13:274-80.
28. Ray PS, Maulik G, Cordis GA, Bertelli AA, Bertelli A, Das DK. The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury. Free Radic Biol Med 1999;27(1-2):160-9. Crossref
29. Turan NN, Akar F, Budak B, Seren M, Parlar AI, Surucu S, et al. How DMSO, a widely used solvent, affects spinal cord injury. Ann Vasc Surg 2008;22:98-105. Crossref
30. Chiueh CC, Wu RM, Mohanakumar KP, Sternberger LM, Krishna G, Obata T, et al. In vivo generation of hydroxyl radicals and MPTPinduced dopaminergic toxicity in the basal ganglia. Ann N Y Acad Sci 1994;738:25-36. Crossref
31. Albin MS, Bunegin L. An experimental study of craniocerebral trauma during ethanol intoxication. Crit Care Med 1986;14:841-6. Crossref
32. Carvalho MO, Barros Filho TE, Tebet MA. Effects of methylprednisolone and ganglioside GM-1 on a spinal lesion: a functional analysis. Clinics (Sao Paulo) 2008;63:375-80. Crossref